Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

  • WCLC 2015

    16th World Conference on Lung Cancer

    Access to all presentations that occur during the 16th World Conference on Lung Cancer in Denver, Colorado

    Presentation Date(s):  
    • September 6 - 9, 2015
    • Total Presentations: 2499

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    IASLC Member Price: $0.00 USD
    Enter Virtual Meeting Access Code
Filter Results:

Show Only Available Presentations

  • +

    JCHS - Joint IASLC - Chinese Society for Clinical Oncology - Chinese Alliance Against Lung Cancer Session

    • Type: Joint Chinese/ English Session
    • Track: Other
    • Presentations: 14
    • Moderators:C. Bai
    • Coordinates: 9/06/2015, 07:30 - 10:30, Mile High Ballroom 1a-1f
  • +

    P1.08 - Poster Session/ Thymoma, Mesothelioma and Other Thoracic Malignancies

    • Type: Poster
    • Track: Thymoma, Mesothelioma and Other Thoracic Malignancies
    • Presentations: 39
    • Coordinates: 9/07/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
    • +

      P1.08-020 - Survival Impact of Adjuvant Radiation and Chemotherapy in Patients with Typical and Atypical Pulmonary Carcinoids

      09:30 - 09:30  |  Author(s): L.M. Hannan

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    ORAL 02 - PD1 Axis Immunotherapy 2

    • Type: Oral Session
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 8
    • Moderators:E.B. Garon
    • Coordinates: 9/07/2015, 10:45 - 12:15, Four Seasons Ballroom F1+F2
    • +

      ORAL02.03 - Longer-Term Follow-Up of a Phase 2 Study (CheckMate 063) of Nivolumab in Patients with Advanced, Refractory Squamous Non-Small Cell Lung Cancer

      11:07 - 11:18  |  Author(s): L. Horn

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    ORAL 05 - Surgery

    • Type: Oral Session
    • Track: Treatment of Locoregional Disease – NSCLC
    • Presentations: 9
    • Moderators:P. Van Schil
    • Coordinates: 9/07/2015, 10:45 - 12:15, 201+203
    • +

      ORAL05.05 - Trimodality Therapy in the Treatment of Stage IIIA Non-Small Cell Lung Cancer (NSCLC): A National Cancer Database Analysis

      11:48 - 11:59  |  Author(s): M. Behera

      • Abstract

      Loading...

  • +

    MS 03 - Is Tumor Angiogenesis Still a Viable Target in Advanced NSCLC?

    • Type: Mini Symposium
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 5
    • Moderators:S. Popat
    • Coordinates: 9/07/2015, 14:15 - 15:45, 605+607
  • +

    MINI 04 - Clinical Care of Lung Cancer

    • Type: Mini Oral
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 15
    • Moderators:L. Gaspar
    • Coordinates: 9/07/2015, 16:45 - 18:15, Mile High Ballroom 2c-3c
    • +

      MINI04.03 - Real-World Patterns of Access to Cancer Specialist Care Among Patients With Lung Cancer in the United States: A Claims Database Analysis

      16:55 - 17:00  |  Author(s): A.K. Ganti

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MINI 05 - EGFR Mutant Lung Cancer 1

    • Type: Mini Oral
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 14
    • Moderators:Y. Yatabe
    • Coordinates: 9/07/2015, 16:45 - 18:15, Mile High Ballroom 2a-3b
  • +

    MINI 09 - Drug Resistance

    • Type: Mini Oral
    • Track: Biology, Pathology, and Molecular Testing
    • Presentations: 14
    • Moderators:L. Villaruz
    • Coordinates: 9/07/2015, 16:45 - 18:15, 205+207
    • +

      MINI09.06 - Oncogenic Drivers including RET and ROS1 plus PTEN Loss and MET by IHC in Patients with Lung Adenocarcinomas: Lung Cancer Mutation Consortium 2.0

      17:15 - 17:20  |  Author(s): B.E. Johnson

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P2.01 - Poster Session/ Treatment of Advanced Diseases – NSCLC

    • Type: Poster
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 102
    • Coordinates: 9/08/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
    • +

      P2.01-011 - Relationship between EGFR Mutation Status and Response to Specific Chemotherapeutic Agents in Patients with Stage IV Non-Small Cell Lung Cancer

      09:30 - 09:30  |  Author(s): V. Ernani

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P2.01-068 - Androgen Deprivation Therapy for Prostate Cancer Associated with Improved Survival in Non Small Cell Lung Cancer: A SEER-MEDICARE Analysis

      09:30 - 09:30  |  Author(s): M. Kumar

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    ORAL 20 - Chemoradiotherapy

    • Type: Oral Session
    • Track: Treatment of Locoregional Disease – NSCLC
    • Presentations: 7
    • Moderators:G. Blumenschein
    • Coordinates: 9/08/2015, 10:45 - 12:15, 201+203
    • +

      ORAL20.01 - A Systematic Review of Carboplatin-Paclitaxel versus Cisplatin-Etoposide Concurrent with Thoracic Radiation for Stage III NSCLC Patients

      10:45 - 10:56  |  Author(s): C. Steuer

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.